Willem F. Lems - Concepedia

Author

Willem F. Lems

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

Corrado Blandizzi, J. D. Adachi, Lems, W., Lems, W. F., Lems, W.F., M L A Landsmeer, M. L. A. Landsmeer, Susan M Ott, W F LEMS, W F Lems

665

Publications

21.9K

Citations

H-Index

116

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Reade Leiden University Medical Center Amsterdam University Medical Centers Vrije Universiteit Amsterdam

About

Willem F. Lems is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, orthopaedics, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	55	2.6K
2	Health Sciences	15	17	761
3	Public Health	3	3	193
4	Engineering	2	2	136
5	Social Sciences	1	1	64

Willem F. Lems

238

Publications

15.7K

Citations

H-Index

Page 1

	Year	Citations
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart, Arthritis & Rheumatism	2005	1.4K
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2007	562
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis Marijn Vis, Willem F. Lems, Alexandre E. Voskuyl, Arthritis & Rheumatism	2006	468
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study Mike J. Peters, Vokko P. van Halm, Alexandre E. Voskuyl, Arthritis Care & Research	2009	363
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation Vokko P. van Halm, Matthew Peters, Alexandre E. Voskuyl, Annals of the Rheumatic Diseases	2008	353
Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus Irene E. M. Bultink, Willem F. Lems, Piet J. Kostense, Arthritis & Rheumatism	2005	248
SCOPE: a scorecard for osteoporosis in Europe J. A. Kanis, F. Borgström, J. Compston, Archives of Osteoporosis	2013	243
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis Marijn Vis, Espen A Havaardsholm, Glenn Haugeberg, Annals of the Rheumatic Diseases	2006	234
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2009	222
Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis R. N. J. de Nijs, Johannes W. G. Jacobs, Willem F. Lems, New England Journal of Medicine	2006	205

Page 1